Barbara A Gower1, Amy M Goss2. 1. Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL bgower@uab.edu. 2. Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL.
Abstract
BACKGROUND:Obesity, particularly visceral and ectopic adiposity, increases the risk of type 2 diabetes. OBJECTIVE: The aim of this study was to determine if restriction of dietary carbohydrate is beneficial for body composition and metabolic health. METHODS: Two studies were conducted. In the first, 69 overweight/obese men and women, 53% of whom were European American (EA) and 47% of whom were African American (AA), were provided with 1 of 2 diets (lower-fat diet: 55%, 18%, and 27% of energy from carbohydrate, protein, and fat, respectively; lower-carbohydrate diet: 43%, 18%, and 39%, respectively) for 8 wk at a eucaloric level and 8 wk at a hypocaloric level. In the second study, 30 women with polycystic ovary syndrome (PCOS) were provided with 2 diets (lower-fat diet: 55%, 18%, and 27% of energy from carbohydrate, protein, and fat, respectively; lower-carbohydrate diet: 41%, 19%, and 40%, respectively) at a eucaloric level for 8 wk in a random-order crossover design. RESULTS: As previously reported, among overweight/obese adults, after the eucaloric phase, participants who consumed the lower-carbohydrate vs. the lower-fat diet lost more intra-abdominal adipose tissue (IAAT) (11 ± 3% vs. 1 ± 3%; P < 0.05). After weight loss, participants who consumed the lower-carbohydrate diet had 4.4% less total fat mass. Original to this report, across the entire 16-wk study, AAs lost more fat mass with a lower-carbohydrate diet (6.2 vs. 2.9 kg; P < 0.01), whereas EAs showed no difference between diets. As previously reported, among women with PCOS, the lower-carbohydrate arm showed decreased fasting insulin (-2.8 μIU/mL; P < 0.001) and fasting glucose (-4.7 mg/dL; P < 0.01) and increased insulin sensitivity (1.06 arbitrary units; P < 0.05) and "dynamic" β-cell response (96.1 · 10(9); P < 0.001). In the lower-carbohydrate arm, women lost both IAAT (-4.8 cm(2); P < 0.01) and intermuscular fat (-1.2 cm(2); P < 0.01). In the lower-fat arm, women lost lean mass (-0.6 kg; P < 0.05). Original to this report, after the lower-carbohydrate arm, the change in IAAT was positively associated with the change in tumor necrosis factor α (P < 0.05). CONCLUSION: A modest reduction in dietary carbohydrate has beneficial effects on body composition, fat distribution, and glucose metabolism. This trial was registered at clinicaltrials.gov as NCT00726908 and NCT01028989.
RCT Entities:
BACKGROUND: Obesity, particularly visceral and ectopic adiposity, increases the risk of type 2 diabetes. OBJECTIVE: The aim of this study was to determine if restriction of dietary carbohydrate is beneficial for body composition and metabolic health. METHODS: Two studies were conducted. In the first, 69 overweight/obesemen and women, 53% of whom were European American (EA) and 47% of whom were African American (AA), were provided with 1 of 2 diets (lower-fat diet: 55%, 18%, and 27% of energy from carbohydrate, protein, and fat, respectively; lower-carbohydrate diet: 43%, 18%, and 39%, respectively) for 8 wk at a eucaloric level and 8 wk at a hypocaloric level. In the second study, 30 women with polycystic ovary syndrome (PCOS) were provided with 2 diets (lower-fat diet: 55%, 18%, and 27% of energy from carbohydrate, protein, and fat, respectively; lower-carbohydrate diet: 41%, 19%, and 40%, respectively) at a eucaloric level for 8 wk in a random-order crossover design. RESULTS: As previously reported, among overweight/obese adults, after the eucaloric phase, participants who consumed the lower-carbohydrate vs. the lower-fat diet lost more intra-abdominal adipose tissue (IAAT) (11 ± 3% vs. 1 ± 3%; P < 0.05). After weight loss, participants who consumed the lower-carbohydrate diet had 4.4% less total fat mass. Original to this report, across the entire 16-wk study, AAs lost more fat mass with a lower-carbohydrate diet (6.2 vs. 2.9 kg; P < 0.01), whereas EAs showed no difference between diets. As previously reported, among women with PCOS, the lower-carbohydrate arm showed decreased fasting insulin (-2.8 μIU/mL; P < 0.001) and fasting glucose (-4.7 mg/dL; P < 0.01) and increased insulin sensitivity (1.06 arbitrary units; P < 0.05) and "dynamic" β-cell response (96.1 · 10(9); P < 0.001). In the lower-carbohydrate arm, women lost both IAAT (-4.8 cm(2); P < 0.01) and intermuscular fat (-1.2 cm(2); P < 0.01). In the lower-fat arm, women lost lean mass (-0.6 kg; P < 0.05). Original to this report, after the lower-carbohydrate arm, the change in IAAT was positively associated with the change in tumor necrosis factor α (P < 0.05). CONCLUSION: A modest reduction in dietary carbohydrate has beneficial effects on body composition, fat distribution, and glucose metabolism. This trial was registered at clinicaltrials.gov as NCT00726908 and NCT01028989.
Authors: F de Carvalho Vidigal; P Guedes Cocate; L Gonçalves Pereira; R de Cássia Gonçalves Alfenas Journal: Nutr Hosp Date: 2012 Sep-Oct Impact factor: 1.057
Authors: Jürgen Meyer; Jeppe Sturis; Martin Katschinski; Rudolf Arnold; Burkhard Göke; Maria M Byrne Journal: Am J Physiol Endocrinol Metab Date: 2002-04 Impact factor: 4.310
Authors: Barbara A Gower; Gary R Hunter; Paula C Chandler-Laney; Jessica A Alvarez; Nikki C Bush Journal: Obesity (Silver Spring) Date: 2009-12-24 Impact factor: 5.002
Authors: Margaux J Barnes; Mary K Lynch; Molly D Lisenby; Traci Jester; Jeanine Maclin; Taylor Knight; Gordon Fisher; Barbara Gower Journal: J Pediatr Gastroenterol Nutr Date: 2019-03 Impact factor: 2.839
Authors: M Caprio; M Infante; E Moriconi; A Armani; A Fabbri; G Mantovani; S Mariani; C Lubrano; E Poggiogalle; S Migliaccio; L M Donini; S Basciani; A Cignarelli; E Conte; G Ceccarini; F Bogazzi; L Cimino; R A Condorelli; S La Vignera; A E Calogero; A Gambineri; L Vignozzi; F Prodam; G Aimaretti; G Linsalata; S Buralli; F Monzani; A Aversa; R Vettor; F Santini; P Vitti; L Gnessi; U Pagotto; F Giorgino; A Colao; A Lenzi Journal: J Endocrinol Invest Date: 2019-05-20 Impact factor: 4.256
Authors: Siew S Lim; Samantha K Hutchison; Emer Van Ryswyk; Robert J Norman; Helena J Teede; Lisa J Moran Journal: Cochrane Database Syst Rev Date: 2019-03-28
Authors: Jamy D Ard; Barbara Gower; Gary Hunter; Christine S Ritchie; David L Roth; Amy Goss; Brooks C Wingo; Eric V Bodner; Cynthia J Brown; David Bryan; David R Buys; Marilyn C Haas; Akilah Dulin Keita; Lee Anne Flagg; Courtney P Williams; Julie L Locher Journal: J Gerontol A Biol Sci Med Sci Date: 2017-12-12 Impact factor: 6.053
Authors: Sarah E Hoover; Barbara A Gower; Yenni E Cedillo; Paula C Chandler-Laney; Sarah E Deemer; Amy M Goss Journal: J Clin Endocrinol Metab Date: 2021-04-23 Impact factor: 5.958